Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Change in Accured Expenses (2016 - 2025)

Corcept Therapeutics (CORT) has disclosed Change in Accured Expenses for 14 consecutive years, with -$17.1 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 259.44% to -$17.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $86000.0 through Dec 2025, down 99.78% year-over-year, with the annual reading at $86000.0 for FY2025, 99.78% down from the prior year.
  • Change in Accured Expenses hit -$17.1 million in Q4 2025 for Corcept Therapeutics, down from $17.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $19.6 million in Q3 2024 to a low of -$17.1 million in Q4 2025.
  • Historically, Change in Accured Expenses has averaged $3.3 million across 5 years, with a median of $4.3 million in 2021.
  • Biggest YoY gain for Change in Accured Expenses was 825.17% in 2023; the steepest drop was 3350.52% in 2023.
  • Year by year, Change in Accured Expenses stood at $7.3 million in 2021, then tumbled by 83.92% to $1.2 million in 2022, then skyrocketed by 825.17% to $10.9 million in 2023, then decreased by 1.89% to $10.7 million in 2024, then plummeted by 259.44% to -$17.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CORT at -$17.1 million in Q4 2025, $17.2 million in Q3 2025, and $5.9 million in Q2 2025.